🔎 Trials Near Me

Home › Autosomal Dominant Polycystic Kidney › Minnesota

Pag-aaral pangklinika para sa Autosomal Dominant Polycystic Kidney sa Minnesota

7 pag-aaral para sa Autosomal Dominant Polycystic Kidney ang naghahanap ng mga kalahok sa mga site sa Minnesota.

Mga Lungsod sa Minnesota

Opisyal na teksto ng pag-aaral (English)

Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease

  • Research Site, Rochester
Nagre-recruitPhase 1
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07228364

ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  • Mayo Clinic Hospital - Rochester, Rochester
Nagre-recruitPhase 2
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06902558

Managing Depressive Symptoms in ADPKD

  • Mayo Clinic, Rochester
Nagre-recruit
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT07745920

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

  • Mayo Clinic, Rochester
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 18 · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT04338048

A Prospective Observational Study of Foam Sclerotherapy .

  • Mayo Clinic, Rochester
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Ene 26, 2026 · NCT04111692

Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  • Mayo Clinic in Rochester, Rochester
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 30 · Lahat ng kasarian · Na-update Ene 16, 2026 · NCT04344769

NOX4 and Related Biomarkers in ADPKD

  • Mayo Clinic, Rochester
Nagre-recruitObservasyonal na pag-aaral
Edad 15 hanggang 40 · Lahat ng kasarian · Na-update Ene 9, 2026 · NCT04630613

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.